Anetoderma: an alert for antiphospholipid antibody syndrome
نویسندگان
چکیده
منابع مشابه
Primary anetoderma and antiphospholipid antibodies
Anetoderma is an elastolytic skin process clinically characterized by circumscribed rounded areas of loose skin; and histologically, by loss of elastic dermal fi bers. Two forms are traditionally distinguished, primary and secondary. Th e latter refers to an abnormal repair mechanism of preexisting skin lesions, where acne and varicella are the most frequent causes. In contrast, in the primary ...
متن کاملANTIPHOSPHOLIPID ANTIBODY SYNDROME-A CASE OF AORTIC VALVE INSUFFICIENCY
A 31 year old woman was hospitalized for evaluation of aortic valve insufficiency and her present cardiac status. Clinical and paraclinical findings strongly suggested the presence of a collagen vascular inflammatory processprecisely, the antiphospholipid antibody syndrome (APS), with systemic lupus erythematosus as the underlying disease.
متن کاملAntiphospholipid antibody syndrome.
The 2006 International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome has increased the time between the two laboratory studies required for diagnosis from 6 to 12 weeks. Antibody to beta2 glycoprotein 1 has been included as a criterion. Various non-criteria diagnostic clues such as livedo reticularis, heart valve disease, thrombocytopenia...
متن کاملAnetoderma before development of antiphospholipid antibodies: delayed development and monitoring of antiphospholipid antibodies in an SLE patient presenting with anetoderma.
INTRODUCTION Anetoderma is an elastolytic skindisorder that has been associated with the presenceof antiphospholipid antibodies (aPL). Patients withantiphospholipid antibody-positive anetoderma havebeen reported to develop symptoms of Graves disease,antiphospholipid syndrome, and other autoimmuneconditions. The temporal relationship, however,between anetoderma onset and the emergence ofaPL rema...
متن کاملTreatment of antiphospholipid antibody syndrome
Antiphospholipid antibody syndrome (APS) is a systemic autoimmune disease with thrombotic predilection resulting in vascular thrombotic events and obstetric complications. Management of APS focuses on anticoagulation; however, despite the solid evidence suggesting that this is the best treatment option available, a lot of debate persists regarding the intensity and duration of anticoagulation n...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Anais Brasileiros de Dermatologia
سال: 2020
ISSN: 0365-0596
DOI: 10.1016/j.abd.2019.04.010